Efficacy of Multimodal Analgesia Following Hip Arthroscopy

Brief summary (from the registry)

The purpose of the full study is to determine whether multimodal analgesia for hip arthroscopy will reduce post-operative pain scores, narcotic consumption and hospital length-of-stay. To do this, the investigators will compare the standard of care (SOC), with routine pain management with a post-operative opioid prescription, to three different groups with multi-modal analgesia (SOC+peri-operative celecoxib, SOC+peri-operative gabapentin, and SOC+post-operative zopiclone). The investigators hypothesize that administration of multi-modal analgesia in all three treatment groups will result in improved post-operative pain control, reduced post-operative narcotic consumption and an overall reduction in post-operative length-of-stay compared to the group receiving treatment as per the standard of care. However, prior to undertaking a large multi-centre study, the investigators need to determine whether the study is feasible from data obtained with this pilot study.

Study details

Official title

Efficacy of Multimodal Analgesia Following Hip Arthroscopy

Conditions

• Hip Pain Chronic

Interventions

• Drug: Zopiclone
• Drug: Gabapentin
• Drug: Celebrex
• Drug: Percocet
• Drug: Naprosyn

Sponsor

Western University, Canada

Start date

2018-04-06

Primary completion

2021-09-30

Sex

All

Age range

from 18 Years to 60 Years

Results posted

No results posted in this snapshot

Countries

Canada

Total sites listed

1

Eligibility criteria

Canadian sites (1)